Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 133 results for "glenmark"

55 images for glenmark

Money Control, 1 week ago
Money Control, 1 week ago
Money Control, 2 weeks ago
Money Control, 2 weeks ago
Money Control, 3 weeks ago
Money Control, 1 month ago
Money Control, 1 month ago
Money Control, 1 month ago
catchnews.com, 1 month ago
Money Control, 1 month ago
Money Control

Buy Glenmark Pharma, Muthoot Capital Services: Mitessh Thakkar

Mitessh Thakkar of mitesshthakkar.com is of the view that one may buy Glenmark Pharma and Muthoot Capital Services.
 Money Control1 week ago Buy Just Dial; sell CONCOR, Glenmark Pharma: Ashwani Gujral  Money Control2 months ago Buy Sun TV, Ujjivan Financial, Glenmark, Bajaj Finserv: Gujral  Money Control2 months ago

Sell Glenmark Pharma; buy BEML, Bharat Forge: Sudarshan Sukhani

Sudarshan Sukhani of s2analytics.com is of the view that one can sell Glenmark Pharma while buy BEML and Bharat Forge.
 Money Control3 weeks ago Sell Glenmark, Mamp;M; buy Siemens, Larsen amp; Toubro, Exide Industries: Sudarshan Sukhani  Money Control1 month ago Sell India Cements, Glenmark Pharma; buy HDFC: Sudarshan Sukhani  Money Control1 month ago Sell Tata Motors, Glenmark Pharma; buy Colgate Palmolive: Sudarshan Sukhani  Money Control1 month ago

Short Glenmark, Just Dial; buy Dabur, Apollo Tyres, Tata Chemicals: Sukhani

Sudarshan Sukhani of s2analytics.com is of the view that one can short Glenmark Pharma and Just Dial while can buy Dabur India, Apollo Tyres and Tata Chemicals.
 Money Control2 weeks ago Buy IndusInd Bank, Bajaj Finance, Tata Chemicals; sell ACC, Glenmark Pharma: Sudarshan Sukhani  Money Control1 month ago
Money Control

Results #39;positive#39; for nasal spray 3rd phase trials: Glenmark

The results for GSP 301, a fixed-dose combination of mometasone furoate 25 mcg and olopatadine hydrochloride 665 mcg are from a recently completed phase III trial assessing its efficacy and safety versus mometasone, olopatadine or placebo, it said in a BSE ...
 Money Control1 month ago Results 'positive' for nasal spray 3rd phase trials: Glenmark  DNA1 month ago
Money Control

Glenmark rises 4% on receipt of inspection report from US FDA

The drug firm received establishment inspection report (EIR) from the US Food and Drug Administration on closure of inspection of its Ankleshwar plant in Gujarat.
 Money Control1 month ago Glenmark's Ankleshwar plant gets EIR report from USFDA  DNA1 month ago Glenmark Pharma receives EIR from USFDA for Ankleshwar plant  Myiris1 month ago Glenmark#39;s Ankleshwar plant gets EIR report from USFDA  Money Control1 month ago
Money Control

Glenmark ties up with Evestra to develop contraceptive

The companies will file for product approval in FY19
 Business Standard1 month ago Glenmark, Evestra enter pact for generic contraceptive product  Money Control1 month ago Glenmark partners Evestra to market contraceptive product in US  Business Standard1 month ago Glenmark Pharma, Evestra ink pact for generic NuvaRing  Myiris1 month ago
Money Control

Bharat Heavy Electricals can climb to Rs 175, Glenmark Rs 880: Prakash Gaba

Prakash Gaba of prakashgaba.com is of the view that Bharat Heavy Electricals can climb to Rs 175 while Glenmark Pharma can test Rs 880.
 Money Control3 weeks ago Glenmark Pharma gets earnings boost  Business Line2 months ago Glenmark Pharma climbs nearly 7% on smart Q3 earnings  DNA2 months ago
Money Control

Buy Glenmark Pharmaceuticals ; target of Rs 1100: Axis Direct

Axis Direct is bullish on Glenmark Pharmaceuticals has recommended buy rating on the stock with a target price of Rs 1100 in its research report dated March 24, 2017.
 Money Control1 month ago Glenmark Pharma may touch Rs 1000: Rajat Bose  Money Control2 months ago Buy Glenmark Pharma; target of Rs 1155: ICICI Direct  Money Control2 months ago Hold Glenmark Pharmaceuticals; target of Rs 820: Edelweiss  Money Control2 months ago
Money Control

USFDA clears Glenmark's investigational new drug application

Drug major Glenmark today said theUS health regulator has cleared its investigational new drug(IND) application to begin a phase two study of GSP 304 to beused for treatment of a respiratory disease.
 Money Control1 month ago Glenmark Pharma receives USFDA nod for IND GSP 304  Myiris1 month ago Glenmark Pharma up 1% on US FDA nod to drug's first phase  Money Control1 month ago Pharma companies seen reporting weak numbers  The Financial Chronicle1 week ago
[x]  
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less